Role of IL-17A in Chronic Rhinosinusitis With Nasal Polyp

다국어 초록 (Multilingual Abstract)

Purpose: Th17-associated inflammation is increased in chronic rhinosinusitis with nasal polyp (CRSwNP), and is associated with disease severity and steroid resistance. Overexpressed interleukin (IL)-17A affects CRSwNP by tissue remodeling, eosinophilic accumulation, and neutrophilic infiltration. We aimed to identify the role of IL-17A in CRSwNP and to evaluate the effects of anti-IL-17A blocking antibody on nasal polyp (NP) formation using a murine NP model. Moreover, we sought to investigate whether the inhibition of mechanistic target of the rapamycin (mTOR) signal pathway could suppress IL-17A expression and NP formation.
Methods: Human sinonasal tissues from control subjects and patients with chronic rhinosinusitis (CRS) were analyzed using immunohistochemistry (IHC) and immunofluorescence staining. The effects of IL-17A neutralizing antibody and rapamycin were evaluated in a murine NP model. Mouse samples were analyzed using IHC, quantitative real-time polymerase chain reaction, and enzyme-linked immunosorbent assay.
Results: IL-17A+ inflammatory cells were significantly increased in number in NP from patients with CRSwNP compared to that in uncinate process tissues from control subjects and patients with CRS without NP or CRSwNP. CD68+ M1 macrophages dominantly expressed IL-17A, followed by neutrophils and T helper cells, in NP tissues. Neutralization of IL-17A effectively reduced the number of NPs, inflammatory cytokines, and IL-17A-producing cells, including M1 macrophages. Inhibition of IL-17A via the mTOR pathway using rapamycin also attenuated NP formation and inflammation in the murine NP model.
Conclusions: IL-17A possibly plays a role in the pathogenesis of CRSwNP, the major cellular source being M1 macrophage in NP tissues. Targeting IL-17A directly or indirectly may be an effective therapeutic strategy for CRSwNP.

참고문헌 (Reference)

1 Chen F, "mTOR mediates IL-23 induction of neutrophil IL-17 and IL-22 production" 196 : 4390-4399, 2016

2 Oakley GM, "The role of macrolides in chronic rhinosinusitis(CRSsNP and CRSwNP)" 17 : 30-, 2017

3 Kim DK, "The role of interleukin-33 in chronic rhinosinusitis" 72 : 635-645, 2017

4 Yu R, "The inhibitory effect of rapamycin on Toll like receptor 4 and interleukin 17 in the early stage of rat diabetic nephropathy" 41 : 55-69, 2016

5 Jiang XD, "The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps" 25 : e171-e175, 2011

6 Wang H, "The activation and function of IL-36γ in neutrophilic inflammation in chronic rhinosinusitis" 141 : 1646-1658, 2018

7 Zhao Y, "Th17 immunity in patients with allergic asthma" 151 : 297-307, 2010

8 McKinley L, "TH17 cells mediate steroidresistant airway inflammation and airway hyperresponsiveness in mice" 181 : 4089-4097, 2008

9 Bettelli E, "TH-17 cells in the circle of immunity and autoimmunity" 8 : 345-350, 2007

10 Kim DW, "Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model" 25 : e255-e261, 2011

11 Jaleel T, "Secukinumab(AIN-457)for the treatment of psoriasis" 9 : 187-202, 2016

12 Saitoh T, "Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma" 151 : 8-16, 2010

13 Nagai S, "Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation" 1280 : 30-34, 2013

14 Ono N, "Relationships between IL-17A and macrophages or MUC5AC in eosinophilic chronic rhinosinusitis and proposed pathological significance" 3 : e50-e54, 2012

15 Makihara S, "Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation" 126 : 397-400.e11, 2010

16 Ko DY, "Rapamycin inhibits transforming growth factor beta 1induced myofibroblast differentiation via the phosphorylated-phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts" 30 : 211-217, 2016

17 Zhang H, "Rapamycin attenuates Tc1 and Tc17 cell responses in cigarette smoke-induced emphysema in mice" 68 : 957-968, 2019

18 Busse WW, "Randomized, double-blind, placebocontrolled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma" 188 : 1294-1302, 2013

19 Annunziato F, "Phenotypic and functional features of human Th17 cells" 204 : 1849-1861, 2007

20 Hai Wang, "Neutrophils as a Protagonist and Target in Chronic Rhinosinusitis" 대한이비인후과학회 12 (12): 337-347, 2019

21 Derycke L, "Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps" 9 : e97581-, 2014

22 Ferrières L, "Long-term continuation with secukinumab in psoriasis : association with patient profile and initial psoriasis clearance" 44 : e230-e234, 2019

23 Hong SL, "Interleukin-17A-induced inflammation does not influence the development of nasal polyps in murine model" 5 : 363-370, 2015

24 Sergejeva S, "Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation" 33 : 248-253, 2005

25 Chiricozzi A, "Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis" 131 : 677-687, 2011

26 Tomassen P, "Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers" 137 : 1449-1456, 2016

27 Buerger C, "Inflammation dependent mTORC1signaling interferes with the switch from keratinocyte proliferation to differentiation" 12 : e0180853-, 2017

28 Irvin C, "Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma" 134 : 1175-1186, 2014

29 Linke R, "Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps" 162 : 290-298, 2013

30 Kato A, "Immunopathology of chronic rhinosinusitis" 64 : 121-130, 2015

31 Golebski K, "IL-1β, IL-23, and TGF-βdrive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation" 10 : 2162-, 2019

32 Ortega C, "IL-17-producing CD8+T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines" 86 : 435-443, 2009

33 Jin W, "IL-17 cytokines in immunity and inflammation" 2 : e60-, 2013

34 Wang CQ, "IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis : potential relevance to psoriasis" 133 : 2741-2752, 2013

35 Shin HW, "Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition" 185 : 944-954, 2012

36 Xiu Q, "Hypoxia regulates IL-17A secretion from nasal polyp epithelial cells" 8 : 102097-102109, 2017

37 Ghoreschi K, "Generation of pathogenic TH17 cells in the absence of TGF-β signalling" 467 : 967-971, 2010

38 Buerger C, "Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target" 9 : 2786-, 2018

39 Fokkens WJ, "EPOS 2012 : European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists" 50 : 1-12, 2012

40 Wang X, "Diversity of TH cytokine profiles in patients with chronic rhinosinusitis : a multicenter study in Europe, Asia, and Oceania" 138 : 1344-1353, 2016

41 Zhang N, "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease" 122 : 961-968, 2008

42 Wang M, "Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps" 144 : 1254-1264, 2019

43 Shah SA, "Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway" 49 : 60-66, 2017

44 김대우, "Can Neutrophils Be a Cellular Biomarker in Asian Chronic Rhinosinusitis?" 대한이비인후과학회 12 (12): 325-326, 2019

45 Chen JY, "Autophagy is deficient in nasal polyps : implications for the pathogenesis of the disease" 5 : 119-123, 2015

46 Leonardi C, "Anti-interleukin-17monoclonal antibody ixekizumab in chronic plaque psoriasis" 366 : 1190-1199, 2012

47 Zaba LC, "Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses" 204 : 3183-3194, 2007

48 Xu G, "Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps" 10 : 13-, 2009

49 Wang YH, "A novel subset of CD4+TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma" 207 : 2479-2491, 2010

50 Park H, "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17" 6 : 1133-1141, 2005